The cortisol-cortisone shuttle in children born with intrauterine growth retardation

M Houang1, G Morineau, Y le Bouc

  • 1Laboratoire d'Explorations Fonctionnelles Endocriniennes, Hopital Trousseau AP-HP, Paris, France.

Pediatric Research
|August 14, 1999
PubMed

Insights

Twenty percent of children with intrauterine growth retardation (IUGR) and poor growth exhibit elevated cortisol/cortisone ratios, suggesting a potential 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) deficit. This may link IUGR to later health issues.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Developmental Biology

Background:

  • Intrauterine growth retardation (IUGR) is linked to nephron deficit and increased risk of cardiovascular diseases, hypertension, glucose intolerance, and dyslipidemia.
  • The enzyme 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2), primarily in the kidney, plays a crucial role in regulating cortisol levels; its deficit can lead to hypertension.

Purpose of the Study:

  • To investigate the potential involvement of 11beta-HSD2 dysfunction in the poor growth rates of children born with IUGR.
  • To assess the relationship between cortisol/cortisone (F/E) ratios and metabolic/cardiovascular markers in IUGR children.

Main Methods:

  • Plasma cortisol (F) and cortisone (E) concentrations, and the F/E ratio, were measured in 40 IUGR children without catch-up growth and 26 controls.
  • Cholesterol, HbA1C, insulin, and glucose levels were also determined.
  • Children were categorized into two groups based on their F/E ratios: Group 1 (high F/E ratio) and Group 2 (normal F/E ratio).

Main Results:

  • Twenty percent of IUGR children (Group 1) exhibited significantly higher F/E ratios (13.15 +/- 4.26) compared to controls (5.5 +/- 1.7) and Group 2 (5.40 +/- 1.43).
  • Group 1 children had significantly lower childhood height, higher systolic blood pressure, and higher cholesterol concentrations compared to Group 2 and controls.
  • Height was negatively correlated with the F/E ratio, and cholesterol levels were positively correlated with the F/E ratio.

Conclusions:

  • A subset of children with IUGR and poor growth demonstrates elevated F/E ratios, indicative of a possible partial 11beta-HSD2 deficit.
  • This finding suggests a potential link between 11beta-HSD2 function during fetal development and long-term health outcomes, including cardiovascular risk.
  • Further evaluation is needed to determine if these children face an increased risk of developing cardiovascular diseases in adulthood.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...